Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-26 · accession 0001628280-26-012539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-26 | BMRN | Friberg Gregory R | EVP, Chief R, D Off | S - Sale | $60.38 | -6,326 | 37.6K | -14% | -$382.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | S | D | 6,326 | $60.38 | 37,578 | D | — | — | (F1) The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.36 to $60.51. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price |